Univest
Univest
  • Markets

Wockhardt Ltd. (WOCKPHARMA) Share Price Rise Streak: Stock rises for second straight session

  • September 3, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Wockhardt Ltd. Share Price Rise Streak
Wockhardt Ltd. (WOCKPHARMA) share price rose to Rs 2,074 today, up 2.31% from the previous close. Market cap was Rs 32,652.76 crore.

Wockhardt Ltd. Share Price Rise Streak is continuing in its second straight session, with the latest traded price at Rs 2,074 and a 3.22% cumulative move across the streak. According to latest Univest figures, the pattern is confirmed, but no company-specific catalyst is established.

Wockhardt Ltd. Share Price Rise Streak matters because it places the stock at a market capitalisation of Rs 32,652.76 crore while keeping the focus on consecutive higher sessions rather than a single-day swing. For readers tracking Wockhardt Ltd. Share Price, the key point is that a run of back-to-back gains can reshape how the move is read, even when the verified data does not establish a specific trigger.

Table of Contents

Toggle
  • Wockhardt Ltd. Share Price Rise Streak: Consecutive Gain Analysis
  • What the Consecutive Gains Show
  • Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Wockhardt Ltd.
  • About Wockhardt Ltd.
  • Frequently Asked Questions
    • What is Wockhardt Ltd. Share Price trading at today?
    • What does the Wockhardt Ltd. Share Price Rise Streak mean?
    • Why is Wockhardt Ltd. Share Price rising today?
    • What was the day’s range for Wockhardt Ltd. Share Price?
    • How does Wockhardt Ltd. Share Price compare with the sector benchmark?
    • What is Wockhardt Ltd. market capitalisation?
    • How do EPS and book value look for Wockhardt Ltd. Share Price?
    • Does Wockhardt Ltd. pay a dividend?
  • Track Wockhardt Ltd. Share Price on Univest

Wockhardt Ltd. Share Price Rise Streak: Consecutive Gain Analysis

Wockhardt Ltd. (WOCKPHARMA) rose to Rs 2,074 from the previous close of Rs 2,027.1, a move of Rs 46.9 or 2.31%. The stock opened at Rs 2,034.65, reached a high of Rs 2,080.4, recorded a low of Rs 1,993.15.

Wockhardt Ltd. Share Price Rise Streak was reflected in a higher latest traded price of Rs 2,074, up Rs 46.90 or 2.31% from the previous close of Rs 2,027.10. The stock opened at Rs 2,034.65, touched a high of Rs 2,080.40 and a low of Rs 1,993.15, and traded near the upper end of that range at the latest reading.

Wockhardt Ltd. Share Price Rise Streak therefore shows a session that moved above the previous close and held close to the day’s high by the time of the latest update. The move is notable because it follows the prior higher session and leaves the stock with a 3.22% cumulative gain across the streak from a base of Rs 2,009.25 on 18 November 2026. Market capitalisation stood at Rs 32,652.76 crore, keeping the price move in a large-capitalisation context even as the session itself is still unfolding. For readers following Wockhardt Ltd. Share Price, the price action remains the first layer of the story before any fundamental read-through.

What the Consecutive Gains Show

The Wockhardt Ltd. Share Price Rise Streak is the main distinguishing feature here: two consecutive higher sessions have produced a 3.22% cumulative gain from the streak base of Rs 2,009.25. That pattern is different from reading one session in isolation, because it shows how the latest price sits after the second upward leg rather than after a single move.

Wockhardt Ltd. Share Price Rise Streak also tells readers that the latest session built on the prior day’s strength instead of resetting the story. The first higher session is the factual anchor, and the second straight session adds follow-through. According to latest Univest figures, the price event is confirmed, but no company-specific catalyst is established. For Wockhardt Ltd. Share Price, that means the streak itself is the verified market event, while the reason for it remains unconfirmed. The practical takeaway is to watch how the next update interacts with the streak base, current price and day range.

Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 32,652.76 crore
P/E Ratio 80.35x
P/B Ratio 6.39x
ROE 4.29%
ROCE 6.79%
EPS Rs 25.23
Book Value Per Share Rs 317.41
Dividend Yield 0%

Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 80.35x, P/B 6.39x, ROE 4.29%, ROCE 6.79%. Read together, these ratios describe the company’s position rather than a recommendation.

Wockhardt Ltd. has a market capitalisation of Rs 32,652.76 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 80.35x, P/B at 6.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 25.23, book value per share of Rs 317.41, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.6x, median ROE of 11.23%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 80.35x
Benchmark Median P/E 30.6x
Benchmark Average P/E 59.27x
Benchmark P/E Range 2.71x to 1,378.1x
Company P/B Ratio 6.39x
Benchmark Median P/B 2.8x
Company ROE 4.29%
Benchmark Median ROE 11.23%
Company ROCE 6.79%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 32,652.76 crore
Benchmark Median Market Cap Rs 789.58 crore

Wockhardt Ltd. (WOCKPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 80.35x, which is above the benchmark median of 30.6x, a difference of +162.58%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.23%, a difference of -61.8%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.1%, a difference of -48.17%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,48,687.64 40.96 5.03 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,95,080.27 87.38 16.33 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,677.43 83.06 9.6 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,26,433.06 93.64 20.7 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,19,969.79 28.52 4.29 19.69 21.39

Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 80.35x compared with the displayed peer median of 83.06x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 4.29% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 32,652.76 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Wockhardt Ltd.

  • Wockhardt Ltd. Share Price Rise Streak is in its second straight session, with a 3.22% cumulative move from Rs 2,009.25.
  • The latest Wockhardt Ltd. Share Price is Rs 2,074, with the stock trading near the upper end of the day’s range.
  • Wockhardt Ltd. Share Price Rise Streak has lifted the valuation lens, with P/E at 80.35 and P/B at 6.39.
  • The Healthcare and Pharmaceuticals & Drugs context matters because Wockhardt’s returns remain below the industry benchmark on ROE and ROCE.
  • Wockhardt Ltd. Share Price Rise Streak is being tracked alongside peers such as Sun Pharma, Divi’s Laboratories and Zydus Lifesciences.

About Wockhardt Ltd.

Wockhardt Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For readers following Wockhardt Ltd. Share Price Rise Streak, the useful business context is that the company belongs to a listed pharma set where valuation and operating returns are often compared across peers with very different market capitalisations and profitability profiles.

Wockhardt Ltd. Share Price today reflects how the market is valuing that business now, while the streak itself is a short-term price event rather than a change in the company’s operating model. The company’s share price, P/E, P/B, ROE, ROCE, EPS and book value help frame the move, but the business context remains rooted in healthcare and pharmaceuticals. For a reader using Wockhardt Ltd. Share Price Rise Streak as the starting point, the right lens is to connect the current trading level to the company’s sector position, valuation and peer set.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is Wockhardt Ltd. Share Price trading at today?

Ans. Wockhardt Ltd. Share Price is trading at Rs 2,074 in the latest update. That is Rs 46.90 or 2.31% above the previous close of Rs 2,027.10, keeping the stock in its second straight session higher.

What does the Wockhardt Ltd. Share Price Rise Streak mean?

Ans. The Wockhardt Ltd. Share Price Rise Streak means the stock has recorded two consecutive higher sessions. The cumulative gain across that run is 3.22%, starting from Rs 2,009.25 on 18 November 2026.

Why is Wockhardt Ltd. Share Price rising today?

Ans. The verified data confirms the rise, but no company-specific catalyst is established. Wockhardt Ltd. Share Price rose to Rs 2,074 from Rs 2,027.10, and the streak now reflects a second straight higher session.

What was the day’s range for Wockhardt Ltd. Share Price?

Ans. Wockhardt Ltd. Share Price opened at Rs 2,034.65, touched a high of Rs 2,080.40 and a low of Rs 1,993.15. The latest traded price sat close to the day’s high when last updated.

How does Wockhardt Ltd. Share Price compare with the sector benchmark?

Ans. Wockhardt Ltd. Share Price is backed by a P/E of 80.35 and P/B of 6.39, both above the same-industry benchmark median. Its ROE and ROCE remain below the benchmark median, which keeps valuation in focus.

What is Wockhardt Ltd. market capitalisation?

Ans. Wockhardt Ltd. has a market capitalisation of Rs 32,652.76 crore. That places Wockhardt Ltd. Share Price in a far larger size bracket than the industry median market cap of Rs 789.58 crore.

How do EPS and book value look for Wockhardt Ltd. Share Price?

Ans. Wockhardt reports EPS of Rs 25.23 and book value of Rs 317.41. These two figures help frame Wockhardt Ltd. Share Price because they show the earnings and accounting base behind the current valuation.

Does Wockhardt Ltd. pay a dividend?

Ans. The dividend yield is 0.00% in the current data set. That means Wockhardt Ltd. Share Price is being read without a dividend yield contribution, so valuation and operating returns matter more in this comparison.

Track Wockhardt Ltd. Share Price on Univest

Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Wockhardt Ltd. Share Price on Univest for live price updates, valuation ratios, 52-week levels and market insights. The same page also helps users monitor Wockhardt Ltd. Share Price Rise Streak against the latest fundamental ratios and sector context without relying on a single trading day.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply